COVID: BioNTech to supply new vaccine very soon to neutralise Omicron
The new vaccine is, however, still expected to be more effective in neutralising the variants currently in circulation, the report said.
Berlin: German biotechnology company BioNTech is planning to start distributing, from early next month, a new Covid-19 vaccine that has been developed to neutralise two Omicron variants. "We will be able to deliver very soon, hopefully at the beginning of September," BioNTech chief executive Ugur Sahin said, DPA news agency reported, citing Der Spiegel. The European Medicines Agency...
Berlin: German biotechnology company BioNTech is planning to start distributing, from early next month, a new Covid-19 vaccine that has been developed to neutralise two Omicron variants.
"We will be able to deliver very soon, hopefully at the beginning of September," BioNTech chief executive Ugur Sahin said, DPA news agency reported, citing Der Spiegel.
The European Medicines Agency (EMA) recently announced that it would decide on applications from BioNTech-Pfizer and Moderna regarding their vaccines adapted for the BA.1 variant of the virus. However, this variant is of declining importance in Europe.
The new vaccine is, however, still expected to be more effective in neutralising the variants currently in circulation, the report said.
The EMA is currently testing a vaccine adapted by BioNTech and its US partner Pfizer for the BA.4 and BA.5 variants currently dominant in Europe.
BioNTech was currently submitting the last documents to the EMA, Sahin told Der Spiegel. "Then things can precede quickly here as well," he said.
Read also: COVID vaccine 73.2 percent effective in children under 5: Pfizer
Meanwhile, a recent report said that the Pfizer-BioNTech Covid-19 vaccine was 73 per cent effective in protecting children ages 6 months through 4 years during the time when the Omicron strain was highly prevalent.
The vaccine was granted Emergency Use Authorisation by the US Food and Drug Administration for this age group on June 17.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd